Top Story

SECURITY: 6-month DAPT performed similar to 12 months with DES implantation

September 30, 2014

Read the Perspective from Dominick J. Angiolillo, MD, PhD

WASHINGTON — The use of a 6-month vs. 12-month regimen of dual antiplatelet therapy yielded comparable outcomes after the implantation of a second-generation drug-eluting stent, suggested findings from the SECURITY trial presented at TCT 2014.

Lead investigator Antonio Colombo, MD, director of the cardiac catheterization laboratory of MO GVM Centro Cuore Columbus/San Raffaele Hospital in Milan, Italy, presented data from the SECURITY trial, which was concurrently published in the Journal of the American College of Cardiology.

Potential liver repair drug CF102 issued US patent

September 30, 2014
Can-Fite BioPharma received a US patent for CF102, a drug under development to repair liver cells and function in patients with hepatocellular carcinoma, according to a…
In the Journals

Lenalidomide active in recurrent ovarian cancer

September 30, 2014
Continuous treatment with lenalidomide demonstrated activity in women with late recurrent ovarian cancer, according to results of a phase 2 study…
figure Meeting News Coverage

International Myeloma Foundation addresses Congress on toxins at Ground Zero

September 30, 2014
On Sept. 10, the International Myeloma Foundation hosted a congressional briefing to raise awareness on the connection between environmental exposure to toxins and…
More News Headlines »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
figure

Nomogram predicted recurrence risk among women who underwent APBI

September 26, 2014
Jessica Wobb, MD, senior resident in radiation oncology at Beaumont Health System in Birmingham, Mich., describes how…
More »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »